Jianhua Rao

5PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisSolid mechanicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2026
Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.

|Jul 03, 2026
Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Mar 15, 2022
Hyperglycemia-triggered ATF6-CHOP pathway aggravates acute inflammatory liver injury by β-catenin signaling.

Chao Yang, Zeng Wang, Yuanchang Hu

|Feb 10, 2022
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.

Jianhua Rao, Hao Wang, Ming Ni

|Jul 17, 2021
miRNA-130b-5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.

Hao Wang, Zeng Wang, Yirui Wang

Pageof 1

Frequent Collaborators

2 joint publications

Feng Cheng

2 joint publications

Xuehao Wang

1 joint publications

Gang Chen

1 joint publications

Yong-Yi Zeng